Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok

Translated title of the contribution: Experiences with the rectal use of chemotherapeutic agent. Part 2. Pharmacokinetic examinations with animals

János Sallai, Ágnes Vernyik, I. Erös, Géza Regdon, Zsuzsanna Gombköto, Judit Németh, Géza Ifj. Regdon

Research output: Contribution to journalArticle

Abstract

The aim of the investigations was to optimise vehicle for trimethoprim (TMP) suppositories ready for clinical trials. The rectal absorption of TMP was studied in anaesthetized rats. The drug liberation properties of the five mixed vehicles with promising in vitro results (Part 1.) were studied. The course of the blood level curves was monitored with serial sampling. The TMP concentration of blood was determined by bioassay. Individual bases were compared with the use of the pharmacokinetic parameters derived from the analysis of the obtained blood level curves, with special respect to biological availability (BA). The extent of bioavailability is influenced considerably by the hydro-, lipo- or lipohydrophilic property of the vehicle. TMP, if incorporated in the proper vehicle, is absorbed well. With three vehicles the extent of absorption exceeded the absorption seen with oral administration on the same model (BA = 38.8%). The best results were achieved with the lipophilic base Witepsol W 35 containing 10% of Polysorbate 20 and 10% of Polysorbate 61 (BA = 63.8%) and with Witepsol W 35 containing 10% of Polysorbate 60 (BA = 64.9%). The hydrophilic Macrogol 1540 vehicle containing 5% of Macrogol 400 had only slightly worse results (BA = 52.9%). In the case of the lipohydrophilic Witepsol W 35 vehicle with 10% of Polysorbate 20 and 10% of Polysorbate 61 content a significant negative exponential relation was found between the administered doses and their respective bioavailability values, this tendency had been observed during the in vitro examinations, too. No such relation was found in the case of the lipophilic Witepsol W 35 vehicle containing 10% of Miglyol 812.

Original languageHungarian
Pages (from-to)229-233
Number of pages5
JournalActa Pharmaceutica Hungarica
Volume68
Issue number4
Publication statusPublished - Jul 1998

Fingerprint

Biological Availability
Polysorbates
Pharmacokinetics
Trimethoprim
Suppositories
Biological Assay
Oral Administration
Clinical Trials
witepsol

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Sallai, J., Vernyik, Á., Erös, I., Regdon, G., Gombköto, Z., Németh, J., & Ifj. Regdon, G. (1998). Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok. Acta Pharmaceutica Hungarica, 68(4), 229-233.

Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok. / Sallai, János; Vernyik, Ágnes; Erös, I.; Regdon, Géza; Gombköto, Zsuzsanna; Németh, Judit; Ifj. Regdon, Géza.

In: Acta Pharmaceutica Hungarica, Vol. 68, No. 4, 07.1998, p. 229-233.

Research output: Contribution to journalArticle

Sallai, J, Vernyik, Á, Erös, I, Regdon, G, Gombköto, Z, Németh, J & Ifj. Regdon, G 1998, 'Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok', Acta Pharmaceutica Hungarica, vol. 68, no. 4, pp. 229-233.
Sallai, János ; Vernyik, Ágnes ; Erös, I. ; Regdon, Géza ; Gombköto, Zsuzsanna ; Németh, Judit ; Ifj. Regdon, Géza. / Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok. In: Acta Pharmaceutica Hungarica. 1998 ; Vol. 68, No. 4. pp. 229-233.
@article{523637ae47234c17b0684f1f263683f1,
title = "Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok",
abstract = "The aim of the investigations was to optimise vehicle for trimethoprim (TMP) suppositories ready for clinical trials. The rectal absorption of TMP was studied in anaesthetized rats. The drug liberation properties of the five mixed vehicles with promising in vitro results (Part 1.) were studied. The course of the blood level curves was monitored with serial sampling. The TMP concentration of blood was determined by bioassay. Individual bases were compared with the use of the pharmacokinetic parameters derived from the analysis of the obtained blood level curves, with special respect to biological availability (BA). The extent of bioavailability is influenced considerably by the hydro-, lipo- or lipohydrophilic property of the vehicle. TMP, if incorporated in the proper vehicle, is absorbed well. With three vehicles the extent of absorption exceeded the absorption seen with oral administration on the same model (BA = 38.8{\%}). The best results were achieved with the lipophilic base Witepsol W 35 containing 10{\%} of Polysorbate 20 and 10{\%} of Polysorbate 61 (BA = 63.8{\%}) and with Witepsol W 35 containing 10{\%} of Polysorbate 60 (BA = 64.9{\%}). The hydrophilic Macrogol 1540 vehicle containing 5{\%} of Macrogol 400 had only slightly worse results (BA = 52.9{\%}). In the case of the lipohydrophilic Witepsol W 35 vehicle with 10{\%} of Polysorbate 20 and 10{\%} of Polysorbate 61 content a significant negative exponential relation was found between the administered doses and their respective bioavailability values, this tendency had been observed during the in vitro examinations, too. No such relation was found in the case of the lipophilic Witepsol W 35 vehicle containing 10{\%} of Miglyol 812.",
author = "J{\'a}nos Sallai and {\'A}gnes Vernyik and I. Er{\"o}s and G{\'e}za Regdon and Zsuzsanna Gombk{\"o}to and Judit N{\'e}meth and {Ifj. Regdon}, G{\'e}za",
year = "1998",
month = "7",
language = "Hungarian",
volume = "68",
pages = "229--233",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "4",

}

TY - JOUR

T1 - Kemoterapias szer rektalis alkalmazasanak tapasztalatai 2. resz. Allatkiserletes farmakokinetikai vizsgalatok

AU - Sallai, János

AU - Vernyik, Ágnes

AU - Erös, I.

AU - Regdon, Géza

AU - Gombköto, Zsuzsanna

AU - Németh, Judit

AU - Ifj. Regdon, Géza

PY - 1998/7

Y1 - 1998/7

N2 - The aim of the investigations was to optimise vehicle for trimethoprim (TMP) suppositories ready for clinical trials. The rectal absorption of TMP was studied in anaesthetized rats. The drug liberation properties of the five mixed vehicles with promising in vitro results (Part 1.) were studied. The course of the blood level curves was monitored with serial sampling. The TMP concentration of blood was determined by bioassay. Individual bases were compared with the use of the pharmacokinetic parameters derived from the analysis of the obtained blood level curves, with special respect to biological availability (BA). The extent of bioavailability is influenced considerably by the hydro-, lipo- or lipohydrophilic property of the vehicle. TMP, if incorporated in the proper vehicle, is absorbed well. With three vehicles the extent of absorption exceeded the absorption seen with oral administration on the same model (BA = 38.8%). The best results were achieved with the lipophilic base Witepsol W 35 containing 10% of Polysorbate 20 and 10% of Polysorbate 61 (BA = 63.8%) and with Witepsol W 35 containing 10% of Polysorbate 60 (BA = 64.9%). The hydrophilic Macrogol 1540 vehicle containing 5% of Macrogol 400 had only slightly worse results (BA = 52.9%). In the case of the lipohydrophilic Witepsol W 35 vehicle with 10% of Polysorbate 20 and 10% of Polysorbate 61 content a significant negative exponential relation was found between the administered doses and their respective bioavailability values, this tendency had been observed during the in vitro examinations, too. No such relation was found in the case of the lipophilic Witepsol W 35 vehicle containing 10% of Miglyol 812.

AB - The aim of the investigations was to optimise vehicle for trimethoprim (TMP) suppositories ready for clinical trials. The rectal absorption of TMP was studied in anaesthetized rats. The drug liberation properties of the five mixed vehicles with promising in vitro results (Part 1.) were studied. The course of the blood level curves was monitored with serial sampling. The TMP concentration of blood was determined by bioassay. Individual bases were compared with the use of the pharmacokinetic parameters derived from the analysis of the obtained blood level curves, with special respect to biological availability (BA). The extent of bioavailability is influenced considerably by the hydro-, lipo- or lipohydrophilic property of the vehicle. TMP, if incorporated in the proper vehicle, is absorbed well. With three vehicles the extent of absorption exceeded the absorption seen with oral administration on the same model (BA = 38.8%). The best results were achieved with the lipophilic base Witepsol W 35 containing 10% of Polysorbate 20 and 10% of Polysorbate 61 (BA = 63.8%) and with Witepsol W 35 containing 10% of Polysorbate 60 (BA = 64.9%). The hydrophilic Macrogol 1540 vehicle containing 5% of Macrogol 400 had only slightly worse results (BA = 52.9%). In the case of the lipohydrophilic Witepsol W 35 vehicle with 10% of Polysorbate 20 and 10% of Polysorbate 61 content a significant negative exponential relation was found between the administered doses and their respective bioavailability values, this tendency had been observed during the in vitro examinations, too. No such relation was found in the case of the lipophilic Witepsol W 35 vehicle containing 10% of Miglyol 812.

UR - http://www.scopus.com/inward/record.url?scp=0031660611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031660611&partnerID=8YFLogxK

M3 - Article

C2 - 9737024

AN - SCOPUS:0031660611

VL - 68

SP - 229

EP - 233

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 4

ER -